LEP and metabolic syndrome: Lastly, serum leptin concentrations were enriched for the GO term G-protein-coupled receptor activity, which have been found to be directly involved in pancreatic β-cell destruction and insulin resistance and remain potential targets for drug therapy for metabolic syndrome and type II diabetes [52].